Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City 11231, Cairo, Egypt; Department of Biochemistry, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt.
Department of Biochemistry, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Girls), Al-Azhar University, Nasr city, Cairo 11823, Egypt.
Pathol Res Pract. 2023 Jul;247:154584. doi: 10.1016/j.prp.2023.154584. Epub 2023 May 30.
Salivary gland cancer (SGC) is immensely heterogeneous, both in terms of its physical manifestation and its aggressiveness. Developing a novel diagnostic and prognostic detection method based on the noninvasive profiling of microribonucleic acids (miRs) could be a goal for the clinical management of these specific malignancies, sparing the patients' valuable time. miRs are promising candidates as prognostic biomarkers and therapeutic targets or factors that can advance the therapy of SGC due to their ability to posttranscriptionally regulate the expression of various genes involved in cell proliferation, differentiation, cell cycle, apoptosis, invasion, and angiogenesis. Depending on their biological function, many miRs may contribute to the development of SGC. Therefore, this article serves as an accelerated study guide for SGC and the biogenesis of miRs. Here, we shall list the miRs whose function in SGC pathogenesis has recently been determined with an emphasis on their potential applications as therapeutic targets. We will also offer a synopsis of the current state of knowledge about oncogenic and tumor suppressor miRs in relation to SGC.
唾液腺癌(SGC)在临床表现和侵袭性方面具有极大的异质性。开发一种基于微小核糖核酸(miRs)无创谱分析的新型诊断和预后检测方法,可能是这些特定恶性肿瘤临床管理的目标,可以为患者节省宝贵的时间。miRs 作为预后生物标志物和治疗靶点具有很大的应用前景,或者可以通过转录后调控涉及细胞增殖、分化、细胞周期、凋亡、侵袭和血管生成的各种基因的表达来推进 SGC 的治疗。根据其生物学功能,许多 miRs 可能有助于 SGC 的发展。因此,本文作为 SGC 和 miRs 生物发生的加速研究指南。在这里,我们将列出最近确定其在 SGC 发病机制中的功能的 miRs,并重点介绍它们作为治疗靶点的潜在应用。我们还将概述与 SGC 相关的致癌和肿瘤抑制 miRs 的当前知识状态。